Blog Posts

Genetics Adviser

May 22, 2025, 09:24

Proud to Support Our Partners who are Advancing the Future of Precision Medicine – Genetics Adviser

Genetics Adviser shared a post on LinkedIn:

“Proud to support our partners who are advancing the future of precision medicine!

Join us at ESHG2025 in Milan as thought leaders from Murdoch Children’s Research Institute (MCRI)’s and Victorian Clinical Genetics Services (VCGS) share their insights on genomic newborn screening.

Don’t miss these important sessions on Monday, May 26 — exploring lifelong data use, program learnings, and clinical outcomes in prospective cohorts.”

Genetics Adviser announced key genomic newborn screening sessions at ESHG2025 featuring experts from MCRI and VCGS. The presentations will address data use, program insights, and outcomes from prospective studies.

Proud to Support Our Partners who are Advancing the Future of Precision Medicine - Genetics Adviser

More posts featuring Genetics Adviser.

cancer ESHG2025 fight against cancer Genetics Adviser Global fight against cancer MCRI Murdoch Children's Research Institute OncoDaily Oncology Precision Medicine VCGS Victorian Clinical Genetics Services

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding

Matt Sherer: ASCO Supports Permanent Medicare Telehealth

New FDA PreCheck Program to Boost U.S. Drug Manufacturing

Vinay Prasad Rejoins FDA Days After Exit